Teva Pharmaceutical Industries Limited TEVA
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| David Amsellem | Piper Sandler | 32.64 $ | 41 $ | 8.36 % | 04/03/2026 |
| Glen Santangelo | Barclays | 33.07 $ | 38 $ | 4.93 % | 30/01/2026 |
| Matt Dellatorre | Goldman Sachs | 24.395 $ | 28 $ | 3.61 % | 06/11/2025 |
| Ashwani Verma | UBS | 21.2 $ | 28 $ | 6.80 % | 18/12/2024 |
| Balaji Prasad | Barclays | 21.2 $ | 28 $ | 6.80 % | 18/12/2024 |
| Balaji Prasad | Barclays | 18.38 $ | 25 $ | 6.62 % | 23/10/2024 |
| Jason Gerberry | Bank of America Securities | 17.75 $ | 22 $ | 4.25 % | 01/10/2024 |
| Ashwani Verma | UBS | 18.425 $ | 26 $ | 7.58 % | 03/09/2024 |
| David Amsellem | Piper Sandler | 18.615 $ | 23 $ | 4.39 % | 28/08/2024 |
| Balaji Prasad | Barclays | 17.43 $ | 22 $ | 4.57 % | 01/08/2024 |
| Jasper Hellweg | Argus Research | 15.81 $ | 20 $ | 4.19 % | 10/07/2024 |
| Ashwani Verma | UBS | 15.81 $ | 24 $ | 8.19 % | 10/07/2024 |
| Balaji Prasad | Barclays | 16.63 $ | 21 $ | 4.37 % | 05/06/2024 |
| Balaji Prasad | Barclays | 16.76 $ | 20 $ | 3.24 % | 23/05/2024 |
| David Amsellem | Piper Sandler | 16.895 $ | 20 $ | 3.11 % | 13/05/2024 |
| David Amsellem | Piper Sandler | 12.01 $ | 19 $ | 6.99 % | 12/02/2024 |
| Glen Santangelo | Jefferies | 11.99 $ | 14 $ | 2.01 % | 23/01/2024 |
| Ashwani Verma | UBS | 7.89 $ | 10 $ | 2.11 % | 13/06/2022 |
| Balaji Prasad | Barclays | 9.79 $ | 13 $ | 3.21 % | 20/04/2022 |